Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 Jul 2024
Historique:
received: 03 11 2023
accepted: 05 05 2024
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: ppublish

Résumé

ATPase cation transporting 13A2 (ATP13A2) is an endolysosomal P-type ATPase known to be a polyamine transporter, explored mostly in neurons. As endolysosomal functions are also crucial in innate immune cells, we aimed to explore the potential role of ATP13A2 in the human immunocellular compartment. We found that human plasmacytoid dendritic cells (pDCs), the professional type I IFN-producing immune cells, especially have a prominent enrichment of ATP13A2 expression in endolysosomal compartments. ATP13A2 knockdown in human pDCs interferes with cytokine induction in response to TLR9/7 activation in response to bona fide ligands. ATP13A2 plays this crucial role in TLR9/7 activation in human pDCs by regulating endolysosomal pH and mitochondrial reactive oxygen generation. This (to our knowledge) hitherto unknown regulatory mechanism in pDCs involving ATP13A2 opens up a new avenue of research, given the crucial role of pDC-derived type I IFNs in protective immunity against infections as well as in the immunopathogenesis of myriad contexts of autoreactive inflammation.

Identifiants

pubmed: 38950331
pii: 266927
doi: 10.4049/jimmunol.2300733
doi:

Substances chimiques

Toll-Like Receptor 9 0
TLR9 protein, human 0
ATP13A2 protein, human 0
Proton-Translocating ATPases EC 3.6.3.14
TLR7 protein, human 0
Reactive Oxygen Species 0
Interferon Type I 0
Toll-Like Receptor 7 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-114

Subventions

Organisme : Department of Science and Technology, Government of Rajasthan (DST)
ID : DST/SJF/LSA-3/2-16-17

Informations de copyright

Copyright © 2024 by The American Association of Immunologists, Inc.

Auteurs

Purbita Bandopadhyay (P)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.
Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

Jafar Sarif (J)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.
Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

Ranit D'Rozario (R)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.
Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

Chinky Shiu Chen Liu (CSC)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.

Bishnu P Sinha (BP)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.
Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

Md Asmaul Hoque (MA)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.
Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

Koustav Chatterjee (K)

Department of Neurology, Institute of Neurosciences Kolkata, Kolkata 700017, India.

Supriyo Choudhury (S)

Department of Neurology, Institute of Neurosciences Kolkata, Kolkata 700017, India.

Hrishikesh Kumar (H)

Department of Neurology, Institute of Neurosciences Kolkata, Kolkata 700017, India.

Deblina Raychaudhuri (D)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.

Dipyaman Ganguly (D)

IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700091, India.
Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH